Sound Pharmaceuticals, Incorporated
Clinical trials sponsored by Sound Pharmaceuticals, Incorporated, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a pill save your hearing after a cochlear implant? Results expected Dec 2026 (estimated)
- Hope for Meniere's sufferers: new drug enters final testing phase Results expected Dec 2026 (estimated)
-
Hope for Meniere's sufferers: new drug enters final testing phase
Disease control OngoingThis study tests a drug called SPI-1005 in 200 adults with Meniere's disease, a condition that causes hearing loss, ringing in the ears, and dizziness. Participants will take the drug twice a day for 6 or 12 months to see if it is safe and tolerable. The goal is to find a treatme…
Phase 3 • Sponsor: Sound Pharmaceuticals, Incorporated • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Hearing loss prevention pill put to the test — but study never started
Prevention CancelledThis study aimed to test whether an oral drug called SPI-1005 (ebselen) could prevent temporary hearing loss caused by loud noise. Researchers planned to enroll adults aged 18-50 with a history of noise exposure and give them the drug or a placebo for 7 days, then measure hearing…
Phase 2 • Sponsor: Sound Pharmaceuticals, Incorporated • Aim: Prevention
Last updated Jun 27, 2026 13:01 UTC
-
New pill aims to stop chemo from stealing hearing
Prevention CancelledThis study was designed to test whether an oral drug called SPI-1005 could prevent hearing loss and ringing in the ears caused by platinum-based chemotherapy. It was planned for adults with advanced lung or head and neck cancer. The study was withdrawn before enrolling any partic…
Phase 2 • Sponsor: Sound Pharmaceuticals, Incorporated • Aim: Prevention
Last updated Jun 27, 2026 13:01 UTC